Lara Diem (Diem Lara)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 10

Top Topics

Cerebrospinal Fluid

Coronavirus Disease

Multiple Sclerosis

Top Venues

Therapeutic advances in neurological disorders

CNS neuroscience & therapeutics

Multiple sclerosis (Houndmills, Basingstoke, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Anina Schwarzwald, Salmen Anke, Alejandro Xavier León Betancourt, Lara Diem, Helly N Hammer, Piotr Radojewski, Michael Rebsamen, Nicole Kamber, Andrew Chan, Robert Hoepner, Christoph Friedli
Anti-neurochondrin antibody as a biomarker in primary autoimmune cerebellar ataxia-a case report and review of the literature. European journal of neurology (2022)
Helly N Hammer, Robert Hoepner, Christoph Friedli, Stephen L Leib, Franziska Suter-Riniker, Lara Diem, Nicole Kamber, Andrew Chan, Salmen Anke, Christian Philipp Kamm
Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients. Vaccines 10 (6) (2022)
Christoph Friedli, Franca Wagner, Hammer Helly Noemi, Kamber Nicole, Wiest Roland, Lara Diem, Chan Andrew, Salmen Anke, Hoepner Robert
Leptomeningeal enhancement under different MS immunotherapies: A monocentric retrospective cohort study of 214 patients. Multiple sclerosis (Houndmills, Basingstoke, England) (2022)
Lara Diem, Livia Fregolente-Gomes, Jan D Warncke, Helly Hammer, Christoph Friedli, Nicole Kamber, Simon Jung, Sandra Bigi, Manuela Funke-Chambour, Andrew Chan, Claudio L Bassetti, Anke Salmen, Robert Hoepner
Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19. Journal of central nervous system disease 14 (2022)
Lara Diem, Anina Schwarzwald, Christoph Friedli, Helly Hammer, Livia Gomes-Fregolente, Jan Warncke, Lea Weber, Nicole Kamber, Andrew Chan, Claudio Bassetti, Salmen Anke, Robert Hoepner
Multidimensional phenotyping of the post-COVID-19 syndrome: A Swiss survey study. CNS neuroscience & therapeutics 28 (12) (2022)
Michael Rebsamen, Christoph Friedli, Piotr Radojewski, Lara Diem, Andrew Chan, Roland Wiest, Salmen Anke, Christian Rummel, Robert Hoepner
Multiple sclerosis as a model to investigate SARS-CoV-2 effect on brain atrophy. CNS neuroscience & therapeutics (2022)
Lara Diem, Andrew Chan
Persisting lymphopenia and dimethyl fumarate: A clinical commentary. Multiple sclerosis (Houndmills, Basingstoke, England) 27 (8) (2021)
Christoph Friedli, Lara Diem, Helly Hammer, Nicole Kamber, Franziska Suter-Riniker, Stephen Leib, Andrew Chan, Cédric Hirzel, Robert Hoepner, Salmen Anke
Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies. Therapeutic advances in neurological disorders 14 (2021)
Panagiotis Chaloulos-Iakovidis, Franca Wagner, Lea Weber, Lara Diem, Andrew Chan, Salmen Anke, Christoph Friedli, Robert Hoepner
Predicting conversion to multiple sclerosis in patients with radiologically isolated syndrome: a retrospective study. Therapeutic advances in neurological disorders 14 (2021)
Lara Diem, Maxine Bürge, Alexander Leichtle, Arsany Hakim, Andrew Chan, Anke Salmen, Maria-Eleptheria Evangelopoulos, Robert Hoepner
Pathological cerebrospinal fluid protein concentration and albumin quotient at relapse predicts short-term disability progression in multiple sclerosis: a retrospective single center observational study. Therapeutic advances in neurological disorders 13 (2020)